4th Quarter - Report

THE DUBERSTEIN GROUP INC. for PHRMA INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax Reform

LobbyistCovered position, as disclosed
DAVID J SCHIAPPA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Children's Health Insurance Program (CHIP) Drug Pricing: H.R.1301 - Department of Defense Appropriations Act, 2017.

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —
DANIEL P MEYER —
DAVID J SCHIAPPA —
ANNE WALL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1301 (115th)

Medicare/Medicaid MMM

IPAB Disapproval Resolution: S.260 (Cornyn) - Protecting Seniors' Access to Medicare Act of 2017 IPAB Repeal: H.R.849 (Roe) - Protecting Seniors' Access to Medicare Act of 2017

LobbyistCovered position, as disclosed
ANNE ELLIOTT BRADBURY —
DANIEL P MEYER —
DAVID J SCHIAPPA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 260 (115th), H.R. 849 (115th)

Budget/Appropriations BUD

Pay-Fors.

LobbyistCovered position, as disclosed
ANNE ELLIOTT BRADBURY —
DANIEL P MEYER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.